| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENERZAIR BREEZHALER 114 micrograme/46 micrograme/136 micrograme | INDACATEROLUM +GLICOPIRONIUM BROMIDUM+MOMETASONUM | PULB. DE INHAL. CAPSULE | R03AL12 | W66830003 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| ENERZAIR BREEZHALER 114 micrograme/46 micrograme/136 micrograme | INDACATEROLUM +GLICOPIRONIUM BROMIDUM+MOMETASONUM | PULB. DE INHAL. CAPSULE | R03AL12 | W66830004 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| ENERZAIR BREEZHALER 114 micrograme/46 micrograme/136 micrograme | INDACATEROLUM +GLICOPIRONIUM BROMIDUM+MOMETASONUM | PULB. DE INHAL. CAPSULE | R03AL12 | W66830005 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082001 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082002 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082003 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082004 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082005 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082006 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082018 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082008 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082009 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082010 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082011 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082012 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082013 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082014 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082015 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082016 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA | ||||||
| ENGERIX B 10 µg/0,5 ml | VACCIN HEPATITIC B | SUSP. INJ. | J07BC01 | W52082017 | GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman